[1]
N. Bobtina, “Diagnostic and Cost Benefits of Tissue Microarray Technology for Multiplex Biomarker Testing in Molecular Oncology: A Libyan Perspective”, LJMR, vol. 20, no. 1, pp. 156–165, Jan. 2026, doi: 10.54361/LJMR.20.1.24.